Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study.
Albertelli M, Rossi G, Nazzari E, Genova C, Biello F, Rijavec E, Dal Bello MG, Patti L, Tagliamento M, Barletta G, Morabito P, Boschetti M, Dotto A, Campana D, Ferone D, Grossi F.
Albertelli M, et al. Among authors: boschetti m.
J Endocrinol Invest. 2024 Jul;47(7):1805-1814. doi: 10.1007/s40618-023-02268-0. Epub 2024 Apr 29.
J Endocrinol Invest. 2024.
PMID: 38683497
Free PMC article.